Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

30
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
30
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

28
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
28
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

26
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
26
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

23
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
23
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

26
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
26
Goiter01:27

Goiter

32
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
32

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cinacalcet Efficacy in Hyperparathyroidism-Chronic Kidney Disease-Non-Dialysis, Hemodialysis, Peritoneal Dialysis, Kidney Transplantation: Critical Review.

Biomedicines·2026
Same author

Hypercalcemia in Patients After Kidney Transplantation.

Cureus·2025
Same author

The Therapeutic Potential of Propranolol and Other Beta-Blockers in Hyperthyroidism.

International journal of molecular sciences·2025
Same author

Exon 11 Polymorphism (rs1126797) in the Thyroid Peroxidase (<i>TPO</i>) Gene Among Caucasian Polish Patients with Autoimmune Thyroiditis: A Short Communication.

International journal of molecular sciences·2025
Same author

Rationale for Testing TP53 Mutations in Thyroid Cancer-Original Data and Meta-Analysis.

International journal of molecular sciences·2025
Same author

Autoimmune Thyroid Disease in Patients with Down Syndrome-Review.

International journal of molecular sciences·2025

Related Experiment Video

Updated: Apr 30, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

2.8K

[Classification and etiology of hyperthyroidism].

Katarzyna Łacka, Magdalena Maria Fraczek

    Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
    |May 1, 2014
    PubMed
    Summary

    Hyperthyroidism, more common in women, stems from various causes like Graves

    Area of Science:

    • Endocrinology
    • Genetics
    • Environmental Health

    Background:

    • Hyperthyroidism affects 0.5-2% of women, significantly rarer in men.
    • Common causes include Graves' disease, toxic multinodular goiter, and thyroid adenoma.
    • Numerous rare etiologies exist, including drug-induced, genetic, and environmental factors.

    Purpose of the Study:

    • To review current data on the etiopathogenesis of hyperthyroidism.
    • To explore genetic and environmental influences on hyperthyroid conditions.

    Main Methods:

    • Literature review of current data on hyperthyroidism etiopathogenesis.
    • Analysis of genetic factors (e.g., HLA-DR3, CD40, CTLA-4) and thyroid-specific genes (e.g., thyroglobulin, TSHR).
    • Examination of environmental and endogenous factors (e.g., iodine, stress, smoking, infections, medications).

    More Related Videos

    Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis
    05:41

    Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis

    Published on: February 9, 2024

    1.3K
    Spontaneous Murine Model of Anaplastic Thyroid Cancer
    05:39

    Spontaneous Murine Model of Anaplastic Thyroid Cancer

    Published on: February 3, 2023

    2.1K

    Related Experiment Videos

    Last Updated: Apr 30, 2026

    Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
    04:39

    Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

    Published on: March 17, 2023

    2.8K
    Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis
    05:41

    Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis

    Published on: February 9, 2024

    1.3K
    Spontaneous Murine Model of Anaplastic Thyroid Cancer
    05:39

    Spontaneous Murine Model of Anaplastic Thyroid Cancer

    Published on: February 3, 2023

    2.1K

    Main Results:

    • Identified numerous genetic predispositions, including specific human leukocyte antigen (HLA) types and thyroid-related genes.
    • Highlighted diverse environmental and endogenous triggers such as iodine intake, stress, infections, and various medications.
    • Detailed rare causes like Hashitoxicosis, amiodarone-induced hyperthyroidism, and drug-induced conditions.

    Conclusions:

    • Hyperthyroidism arises from a complex interplay of genetic susceptibility and environmental/endogenous factors.
    • Understanding these etiopathogenic elements is crucial for managing and potentially preventing hyperthyroidism.
    • Further research into gene-environment interactions can elucidate specific risk pathways.